Trachomatis (CT)/Neisseria
Gonorrhoeae (NG)
Diagnostic Equipment
Market
Molecular Chlamydia Trachomatis (CT)/Neisseria
Gonorrhoeae (NG) Diagnostic Equipment Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Size and Growth
The Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) diagnostic equipment market is expanding due to rising STD prevalence and increased public awareness. The market size is projected to reach approximately USD 1.5 billion by 2028, driven by advancements in molecular diagnostics and growing demand for accurate, rapid testing solutions in healthcare settings.
Companies Covered
(Covid 19 Impact Covered)
◍ Cepheid
◍ Beckton Dickinson
◍ Gen Probe (Hologic)
◍ Qiagen
◍ Roche
◍ Bayer Healthcare
◍ Dako
◍ Abbott Laboratories
◍ Danaher
◍ Siemens
◍ Sysmex
◍ Grifols
◍ Biomérieux
The Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) diagnostic equipment market is competitive, with key players like Cepheid, Beckton Dickinson, and Roche driving innovation. These companies enhance market growth through advanced testing solutions, expanding product portfolios, and strategic partnerships. Revenue highlights include:
- Roche: $65.5 billion
- Abbott Laboratories: $43.1 billion
- Danaher: $29.2 billion
Request Sample Report
Market Segmentation
By Application
Hospital
Research
Clinic
By Product
◍ Pcr
◍ In Situ Hybridization
◍ Chips And Microarrays
Others Request Sample Report
◍ Isothermal Nucleic Acid Amplification Technology (Inaat)
◍ Mass Spectrometry ◍ Sequencing ◍ Transcription Mediated Amplification
Market Growth
Request Sample Report
$ X Billion USD
